Comments
Loading...

Spero Therapeutics Stock Price, Quotes and Forecasts

SPRONASDAQ
Logo brought to you by Benzinga Data
$0.8450
0.078.95%
Edge Rankings

Spero Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:SPRO | Benzinga

Explore Spero Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for SPRO.

60%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trends and Forecast
1
Oct 24
2
Nov 24
1
Dec 24
1
Jan
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
2.3
Sell
Strong Buy
Buy
Hold
Sell
Strong Sell
Open$0.77
Close-
Volume / Avg.34.96K / 220.48K
Day Range$0.77 - $0.82
52 Wk Range0.74 - 1.89
Market Cap$46.07M
P/E Ratio9.73
Dividend Yield-
ExchangeNASDAQ
RSI
39
Short Interest-
Days to Cover1.29
About Spero Therapeutics Inc
Sector
Health Care
Industry
Biotechnology

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
SPRO

FAQ

Q

How do I buy Spero Therapeutics (SPRO) stock?

A

You can purchase shares of Spero Therapeutics (NASDAQ:SPRO) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Spero Therapeutics (SPRO) competitors?

A

There are no as such competitors for Spero Therapeutics.

Q

What is the forecast, or price target, for Spero Therapeutics (SPRO) stock?

A

Spero Therapeutics has a consensus price target of $4.00.

Q

What is the current price for Spero Therapeutics (SPRO)?

A

The stock price for Spero Therapeutics (NASDAQ: SPRO) is $0.845 last updated March 3, 2025 at 7:01 AM EST.

Q

Does Spero Therapeutics (SPRO) pay a dividend?

A

A quarterly cash dividend of 0.01 per share of Class A Common Stock. The quarterly cash dividend was payable on October 7, 2015 to stockholders of record on September 16, 2015.

Q

When is Spero Therapeutics (NASDAQ:SPRO) reporting earnings?

A

Spero Therapeutics’s Q1 earnings are confirmed for Wednesday, May 14, 2025.

Q

Is Spero Therapeutics (SPRO) going to split?

A

There is no upcoming split for Spero Therapeutics.

Q

What sector and industry does Spero Therapeutics (SPRO) operate in?

A

Spero Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.